Oura launches US IPO with $40-$44 price range, 50M shares

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • ŌURA launches IPO of 50M shares at $40-$44 price range
  • Existing stockholders sell 36.5M shares; company sells 13.5M
  • Expects 5.7M paid members by end of FY26, up 96% YoY
  • Goldman Sachs, Morgan Stanley, J.P. Morgan lead the deal
powered bylight_fuzz_icon
51534668

*this image is generated using AI for illustrative purposes only.

Health intelligence platform ŌURA has launched its initial public offering of 50,000,000 shares of common stock on the Nasdaq Global Select Market under the ticker symbol "OURA." The offering price is expected to be between $40.00 and $44.00 per share.

The offering consists of 13,500,000 shares offered by ŌURA and 36,500,000 shares offered by certain existing stockholders. Underwriters have a 30-day option to purchase up to an additional 7,500,000 shares. ŌURA will not receive proceeds from the sale of shares by the selling stockholders.

Offering Structure

Goldman Sachs & Co. LLC, Morgan Stanley, J.P. Morgan, Allen & Company LLC, and Jefferies act as joint lead book-running managers. BofA Securities, Barclays, and Wells Fargo Securities are joint book-running managers. Citizens Capital Markets, KeyBanc Capital Markets, and Guggenheim Securities serve as book-running managers. Canaccord Genuity, Needham & Company, Raymond James, Rothschild & Co, Truist Securities, and William Blair are additional book-running managers. Robinhood acts as a co-manager.

Growth Metrics

ŌURA updated its S-1 filing on September 21, 2026, to reflect expectations of ending fiscal 2026 with approximately 5.7 million Paid Members. This represents 96 percent year-over-year growth. The company attributes this momentum primarily to strong sales of the Oura Ring 5.

Metric Value
Total Shares Offered 50,000,000
Price Range $40.00 - $44.00
Expected Paid Members (FY26) 5.7 million
Member Growth (YoY) 96%

A registration statement on Form S-1 has been filed with the SEC but has not yet become effective. The securities may not be sold prior to effectiveness.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the significant portion of shares offered by existing stockholders impact early investor sentiment and potential selling pressure post-listing?

Will the 96% year-over-year member growth rate be sustainable as the wearable health market becomes increasingly saturated with competitors?

How will ŌURA allocate the proceeds from its portion of the IPO to drive future R&D or expansion into new product categories beyond the Oura Ring 5?

like16
dislike

Oura signs England stars Kane and Rice as global ambassadors

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Oura has partnered with England footballers Harry Kane and Declan Rice as global brand ambassadors to promote Oura Ring 5. The players will use the device for health tracking and recovery. A marketing campaign featuring the athletes launches this week across digital and TV platforms.

powered bylight_fuzz_icon
42733513

*this image is generated using AI for illustrative purposes only.

Oura, the maker of the Oura Ring, has entered long-term partnerships with England footballers Harry Kane and Declan Rice to serve as global brand ambassadors. The collaboration focuses on promoting Oura Ring 5, which the players will utilize for health sensing to support performance, resilience, and recovery during the upcoming football season. The partnership begins as Kane continues as captain and Rice assumes the role of vice-captain on the international stage.

Kane and Rice selected Oura Ring 5 for its ability to provide a complete view of how their bodies cope with physical load. The device offers personalized insights to help athletes track recovery and readiness. Oura Ring 5, launched in May 2026, is 40 percent smaller than its predecessor and is designed to measure health signals from the finger for accuracy.

As global ambassadors, Kane and Rice will headline a major integrated marketing campaign launching this week. The campaign includes digital out-of-home placements at high-footfall locations such as Piccadilly Circus, BOXPARK Wembley, and Canary Wharf. Additionally, the athletes will appear in primetime TV placements around major football moments this summer.

Doug Sweeny, chief marketing officer at Oura, stated that the partnership highlights the importance of sleep and recovery in achieving peak performance. He noted that the competitive edge comes from listening to the body, a principle Oura aims to support through its technology.

This partnership expands Oura's presence in sports. The company was recently named the Official Wearable of Team USA and the LA28 Olympic and Paralympic Games. It also holds partnerships with Team Finland, U.S. Soccer, and the United States Tennis Association (USTA).

Key Details of the Partnership

Aspect Details
Product Oura Ring 5
Launch Date May 2026
Size Reduction 40 percent smaller than predecessor
Campaign Locations Piccadilly Circus, BOXPARK Wembley, Canary Wharf
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Will the endorsement of elite footballers accelerate mainstream adoption of the Oura Ring 5 among casual fitness enthusiasts?

How will Oura leverage data from Kane and Rice to refine its algorithms for high-performance athletes?

Could this partnership lead to similar collaborations with other major football clubs or national teams?

like15
dislike